Safety and Efficacy of TareSphere in Patients With Unresectable Hepatocellular Carcinoma
Clinical trial NCT06310590 · COMPLETED
Trial details
- NCT number
- NCT06310590
- Sponsor
- Chengdu New Radiomedicine Technology Co. LTD.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-08
- Primary completion
- 2025-06-10
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.